Serum Erythropoietin, Insulin-Like Growth Factor 1 and Vascular Endothelial Growth Factor in Ethiopathogenesis of Retinopathy of Prematurity
Pur po se: The aim of this study was to determine the serum levels of erythropoietin (EPO), vascular endothelial growth factor (VEGF) and insulin-like growth factor-1 (IGF-1) that possibly play an important role in the pathogenesis of retinopathy of prematurity (ROP) and to investigate their relat...
Main Authors: | Özlem Yenice, Ahmed Ashour, Eren Çerman |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Yayinevi
2012-12-01
|
Series: | Türk Oftalmoloji Dergisi |
Subjects: | |
Online Access: | http://www.oftalmoloji.org/article_2204/Serum-Erythropoietin-Insulin-like-Growth-Factor-1-And-Vascular-Endothelial-Growt-Factor-In-Ethiopathogenesis-Of-Retinopathy-Of-Prematurity |
Similar Items
-
Anti-vascular endothelial growth factor in the management of retinopathy of prematurity: A survey among the members of Indian Retinopathy of Prematurity Society
by: Anil Gangwe, et al.
Published: (2021-01-01) -
Effect of early prophylactic low-dose recombinant human erythropoietin on retinopathy of prematurity in very preterm infants
by: Huiqing Sun, et al.
Published: (2020-10-01) -
Early Erythropoietin Administration does not Increase the Risk of Retinopathy in Preterm Infants
by: Hsin-Hsu Chou, et al.
Published: (2017-02-01) -
The efficacy of intravitreal antivascular endothelial growth factor as primary treatment of retinopathy of prematurity: Experience from a tertiary hospital
by: H Kana, et al.
Published: (2017-03-01) -
The Role of Retinopathy Anemia in the Pathogenesis of Retinopathy of Prematurity and the Effect of Erythropoietin Treatment on the Frequency and Severity of the Disease
by: V. I. Lebedev, et al.
Published: (2020-11-01)